This company has been marked as potentially delisted and may not be actively trading. Third Harmonic Bio (THRD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock THRD vs. PRAX, UPB, URGN, QURE, FTRE, GERN, TRVI, PHAT, AVXL, and IMNMShould you be buying Third Harmonic Bio stock or one of its competitors? The main competitors of Third Harmonic Bio include Praxis Precision Medicines (PRAX), Upstream Bio (UPB), Urogen Pharma (URGN), uniQure (QURE), Fortrea (FTRE), Geron (GERN), Trevi Therapeutics (TRVI), Phathom Pharmaceuticals (PHAT), Anavex Life Sciences (AVXL), and Immunome (IMNM). These companies are all part of the "med - biomed/gene" industry. Third Harmonic Bio vs. Its Competitors Praxis Precision Medicines Upstream Bio Urogen Pharma uniQure Fortrea Geron Trevi Therapeutics Phathom Pharmaceuticals Anavex Life Sciences Immunome Third Harmonic Bio (NASDAQ:THRD) and Praxis Precision Medicines (NASDAQ:PRAX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Do analysts rate THRD or PRAX? Third Harmonic Bio currently has a consensus price target of $5.00, suggesting a potential downside of 7.06%. Praxis Precision Medicines has a consensus price target of $85.88, suggesting a potential upside of 83.30%. Given Praxis Precision Medicines' stronger consensus rating and higher probable upside, analysts plainly believe Praxis Precision Medicines is more favorable than Third Harmonic Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Third Harmonic Bio 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Praxis Precision Medicines 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.90 Does the media favor THRD or PRAX? In the previous week, Praxis Precision Medicines had 24 more articles in the media than Third Harmonic Bio. MarketBeat recorded 24 mentions for Praxis Precision Medicines and 0 mentions for Third Harmonic Bio. Praxis Precision Medicines' average media sentiment score of 1.06 beat Third Harmonic Bio's score of 0.00 indicating that Praxis Precision Medicines is being referred to more favorably in the news media. Company Overall Sentiment Third Harmonic Bio Neutral Praxis Precision Medicines Positive Which has more risk & volatility, THRD or PRAX? Third Harmonic Bio has a beta of 2.12, meaning that its share price is 112% more volatile than the S&P 500. Comparatively, Praxis Precision Medicines has a beta of 2.61, meaning that its share price is 161% more volatile than the S&P 500. Do insiders & institutionals have more ownership in THRD or PRAX? 94.0% of Third Harmonic Bio shares are held by institutional investors. Comparatively, 67.8% of Praxis Precision Medicines shares are held by institutional investors. 7.8% of Third Harmonic Bio shares are held by insiders. Comparatively, 2.7% of Praxis Precision Medicines shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is THRD or PRAX more profitable? Third Harmonic Bio has a net margin of 0.00% compared to Praxis Precision Medicines' net margin of -2,137.48%. Third Harmonic Bio's return on equity of -19.27% beat Praxis Precision Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Third Harmonic BioN/A -19.27% -18.67% Praxis Precision Medicines -2,137.48%-60.07%-54.84% Which has better earnings and valuation, THRD or PRAX? Third Harmonic Bio has higher earnings, but lower revenue than Praxis Precision Medicines. Third Harmonic Bio is trading at a lower price-to-earnings ratio than Praxis Precision Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThird Harmonic BioN/AN/A-$45.47M-$0.62-8.68Praxis Precision Medicines$7.77M126.98-$182.82M-$12.29-3.81 SummaryPraxis Precision Medicines beats Third Harmonic Bio on 9 of the 16 factors compared between the two stocks. Get Third Harmonic Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding THRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRD vs. The Competition Export to ExcelMetricThird Harmonic BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$242.80M$3.17B$5.83B$9.92BDividend YieldN/A2.26%6.70%4.51%P/E Ratio-4.3721.2476.2926.13Price / SalesN/A433.21530.72175.33Price / CashN/A45.7236.9959.28Price / Book0.859.8711.486.09Net Income-$45.47M-$53.42M$3.29B$266.51M Third Harmonic Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRDThird Harmonic Bio0.2465 of 5 stars$5.38flat$5.00-7.1%N/A$242.80MN/A-4.37N/APRAXPraxis Precision Medicines2.6706 of 5 stars$44.94-1.3%$85.88+91.1%-13.3%$958.42M$8.55M-3.66110Trending NewsAnalyst ForecastAnalyst RevisionUPBUpstream Bio2.2308 of 5 stars$20.26+18.3%$56.50+178.9%N/A$923.47M$2.37M0.0038News CoveragePositive NewsHigh Trading VolumeURGNUrogen Pharma4.4818 of 5 stars$19.53+0.4%$32.00+63.9%+42.7%$899.84M$90.40M-5.88200News CoveragePositive NewsQUREuniQure2.4581 of 5 stars$17.01+4.2%$37.45+120.2%+231.2%$895.98M$27.12M-4.34500News CoverageAnalyst ForecastFTREFortrea3.149 of 5 stars$10.01+1.6%$12.22+22.1%-42.1%$894.38M$2.70B-0.8815,500News CoveragePositive NewsAnalyst ForecastInsider TradeGap UpGERNGeron3.1122 of 5 stars$1.47+5.0%$4.19+184.9%-67.1%$893.22M$76.99M-11.31229News CoveragePositive NewsTRVITrevi Therapeutics3.0775 of 5 stars$7.27+0.1%$20.11+176.6%+137.6%$883.49MN/A-17.3120PHATPhathom Pharmaceuticals3.144 of 5 stars$11.85-2.7%$17.50+47.7%-30.4%$864.09M$55.25M-2.51110AVXLAnavex Life Sciences3.8698 of 5 stars$9.48-1.7%$44.00+364.1%+82.5%$828.02MN/A-16.6340Positive NewsIMNMImmunome2.2976 of 5 stars$9.28-2.4%$22.50+142.5%-22.3%$827.80M$9.04M-3.0140News CoverageAnalyst ForecastGap Up Related Companies and Tools Related Companies Praxis Precision Medicines Competitors Upstream Bio Competitors Urogen Pharma Competitors uniQure Competitors Fortrea Competitors Geron Competitors Trevi Therapeutics Competitors Phathom Pharmaceuticals Competitors Anavex Life Sciences Competitors Immunome Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THRD) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Third Harmonic Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Third Harmonic Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THRD Stock Alerts